TY - JOUR
T1 - Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells
AU - Reigstad, Christopher S.
AU - Salmonson, Charles E.
AU - Rainey, John F.
AU - Szurszewski, Joseph H.
AU - Linden, David R.
AU - Sonnenburg, Justin L.
AU - Farrugia, Gianrico
AU - Kashyap, Purna C.
N1 - Publisher Copyright:
© FASEB.
PY - 2015/4/1
Y1 - 2015/4/1
N2 - Gut microbiota alterations have been described in several diseases with altered gastrointestinal (GI) motility, and awareness is increasing regarding the role of the gut microbiome in modulating GI function. Serotonin [5-hydroxytryptamine (5-HT)] is a key regulator of GI motility and secretion. To determine the relationship among gut microbes, colonic contractility, and host serotonergic gene expression, we evaluated mice that were germ-free (GF) or humanized (HM; ex-GF colonized with human gut microbiota). 5-HT reduced contractile duration in both GF and HM colons. Microbiota from HM and conventionally raised (CR) mice significantly increased colonic mRNAs Tph1 [(tryptophan hydroxylase) 1, rate limiting for mucosal 5-HT synthesis; P < 0.01] and chromogranin A (neuroendocrine secretion; P < 0.01), with no effect on monoamine oxidase A (serotonin catabolism), serotonin receptor 5-HT4 , or mouse serotonin transporter. HM and CR mice also had increased colonic Tph1 protein (P < 0.05) and 5-HT concentrations (GF, 17 ± 3 ng/mg; HM, 25 ± 2 ng/mg; and CR, 35 ± 3 ng/mg; P < 0.05). Enterochromaffin (EC) cell numbers (cells producing 5-HT) were unchanged. Short-chain fatty acids (SCFAs) promoted TPH1 transcription in BON cells (human EC cell model). Thus, gut microbiota acting through SCFAs are important determinants of enteric 5-HT production and homeostasis.
AB - Gut microbiota alterations have been described in several diseases with altered gastrointestinal (GI) motility, and awareness is increasing regarding the role of the gut microbiome in modulating GI function. Serotonin [5-hydroxytryptamine (5-HT)] is a key regulator of GI motility and secretion. To determine the relationship among gut microbes, colonic contractility, and host serotonergic gene expression, we evaluated mice that were germ-free (GF) or humanized (HM; ex-GF colonized with human gut microbiota). 5-HT reduced contractile duration in both GF and HM colons. Microbiota from HM and conventionally raised (CR) mice significantly increased colonic mRNAs Tph1 [(tryptophan hydroxylase) 1, rate limiting for mucosal 5-HT synthesis; P < 0.01] and chromogranin A (neuroendocrine secretion; P < 0.01), with no effect on monoamine oxidase A (serotonin catabolism), serotonin receptor 5-HT4 , or mouse serotonin transporter. HM and CR mice also had increased colonic Tph1 protein (P < 0.05) and 5-HT concentrations (GF, 17 ± 3 ng/mg; HM, 25 ± 2 ng/mg; and CR, 35 ± 3 ng/mg; P < 0.05). Enterochromaffin (EC) cell numbers (cells producing 5-HT) were unchanged. Short-chain fatty acids (SCFAs) promoted TPH1 transcription in BON cells (human EC cell model). Thus, gut microbiota acting through SCFAs are important determinants of enteric 5-HT production and homeostasis.
KW - 5-hydroxytryptamine
KW - Gnotobiotic
KW - Gut motility
KW - Host-microbe interaction
KW - Microbiome
UR - http://www.scopus.com/inward/record.url?scp=84937394501&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84937394501&partnerID=8YFLogxK
U2 - 10.1096/fj.14-259598
DO - 10.1096/fj.14-259598
M3 - Article
C2 - 25550456
AN - SCOPUS:84937394501
SN - 0892-6638
VL - 29
SP - 1395
EP - 1403
JO - FASEB Journal
JF - FASEB Journal
IS - 4
ER -